Smoldering and polarized inflammation in the initiation and promotion of malignant disease

被引：1479
作者：
Balkwill, F [1 ]
Charles, KA
Mantovani, A
机构：
[1] Barts & London Queen Marys Med Sch, Translat Oncol Lab, Canc Res UK, London EC1M 6BQ, England
[2] Ist Ric Farmacol Mario Negri, Dept Immunol & Cell Biol, I-20157 Milan, Italy
[3] Univ Milan, I-20157 Milan, Italy
来源：
CANCER CELL | 2005年 / 7卷 / 03期
关键词：
D O I：
10.1016/j.ccr.2005.02.013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：211 / 217
页数：7
相关论文
共 83 条
[1]   Interleukin 1-dependent and -independent mouse melanoma metastases [J].
Anasagasti, MJ ;
Olaso, E ;
Calvo, F ;
Mendoza, L ;
Martin, JJ ;
Bidaurrazaga, J ;
VidalVanaclocha, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (09) :645-651
[2]   Interleukin-1 - a major pleiotropic cyrtokine in tumor-host interactions [J].
Apte, RN ;
Voronov, E .
SEMINARS IN CANCER BIOLOGY, 2002, 12 (04) :277-290
[3]   Tumour necrosis factor-α mediates tumour promotion via a PKCα- and AP-1-dependent pathway [J].
Arnott, CH ;
Scott, KA ;
Moore, RJ ;
Hewer, A ;
Phillips, DH ;
Parker, P ;
Balkwill, FR ;
Owens, DM .
ONCOGENE, 2002, 21 (31) :4728-4738
[4]   Expression of both TNF-α receptor subtypes is essential for optimal skin tumour development [J].
Arnott, CH ;
Scott, KA ;
Moore, RJ ;
Robinson, SC ;
Thompson, RG ;
Balkwill, FR .
ONCOGENE, 2004, 23 (10) :1902-1910
[5]   Interleukin-1β inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance [J].
Assenat, E ;
Gerbal-Chaloin, S ;
Larrey, D ;
Saric, J ;
Fabre, JM ;
Maurel, P ;
Vilarem, MJ ;
Pascussi, JM .
HEPATOLOGY, 2004, 40 (04) :951-960
[6]   Tumor necrosis factor or tumor promoting factor? [J].
Balkwill, F .
CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (02) :135-141
[7]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[8]  
BALKWILL FR, 2004, IN PRESS NAT REV CAN
[9]   BIOLOGIC EFFECTS OF ANTI-INTERLEUKIN-6 MURINE MONOCLONAL-ANTIBODY IN ADVANCED MULTIPLE-MYELOMA [J].
BATAILLE, R ;
BARLOGIE, B ;
LU, ZY ;
ROSSI, JF ;
LAVABREBERTRAND, T ;
BECK, T ;
WIJDENES, J ;
BROCHIER, J ;
KLEIN, B .
BLOOD, 1995, 86 (02) :685-691
[10]   TGF-β suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling [J].
Becker, C ;
Fantini, MC ;
Schramm, C ;
Lehr, HA ;
Wirtz, S ;
Nikolaev, A ;
Burg, J ;
Strand, S ;
Kiesslich, R ;
Huber, S ;
Ito, H ;
Nishimoto, N ;
Yoshizaki, K ;
Nishimoto, N ;
Galle, PR ;
Blessing, M ;
Rose-John, S ;
Neurath, MF .
IMMUNITY, 2004, 21 (04) :491-501
123456789